Suvorexant Trial for AUD and PTSD
Phase 2
76
about 12 months
21–65
2 sites in CA, TX
About this study
This trial is testing if suvorexant (SUV) can reduce insomnia in adults with post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD). Participants will receive either a placebo or SUV, followed by a two-week abstinence period from alcohol. They will track their symptoms using daily diaries and attend clinic visits to assess outcomes.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take Suvorexant
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
suvorexant
oral (Oral Tablet)
Primary: Change in Insomnia Severity Index (ISI) score from baseline to Day 14.
Secondary: Change in PTSD total symptom severity score as measured by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) from baseline to Day 14.
Psychiatry / Mental Health